Huakang Stock's Announcement on Satisfaction of Price Adjustment Conditions for Huakang Convertible Bonds
Announcement of Huakang Corporation regarding its subsidiary receiving an administrative penalty decision from the Weifang Ecological Environment Bureau.
Announcement of Huakang Corporation on the Joint Establishment of a New Company and the Signing of the "Investment Cooperation Agreement"
Huakang Stock's Response Announcement regarding Shanghai Stock Exchange's Regulatory Letter on the Company's 2023 Annual Report Disclosure
Tianjian Certified Public Accountants (special general partnership) Special Explanation on Information Disclosure and Regulatory Work Letter for Huakang Shares' 2023 Annual Report.
Announcement of Huakang Corporation on using some idle funds raised to redeem due for cash management.
Orient Securities Co., Ltd. Underwriting & Sponsorship Co., Ltd. entrusted management report on the issuance of convertible corporate bonds by Zhejiang Huakang Pharmaceutical Co., Ltd. to unspecified objects (2023)
In 2023, Zhejiang Huakang Pharmaceutical Co., Ltd. will issue convertible enterprise bonds to unspecified investors, and a follow-up credit rating report will be released in 2024.
Announcement of Huakang's follow-up rating results for Huakang convertible bonds in 2024.
Announcement of Huakang Convertible Bonds starting to be converted to shares
Investor relations activity record form of Zhejiang Huakang Pharmaceutical Co., Ltd. 2024-002
Announcement of Huakang Co., Ltd. on receiving dividends from wholly-owned subsidiaries
Huakang Co., Ltd. 2023 Equity Distribution Implementation Notice
Announcement of Huakang Co., Ltd. on adjusting the conversion price of “Huakang Bonds” due to the implementation of equity distribution
Huakang Co., Ltd.'s progress announcement on the use of some idle funds raised for cash management
Announcement of Huakang Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Huakang Co.
Legal Opinion of Guohao Lawyers (Hangzhou) Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Huakang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 13th Meeting of the 6th Board of Supervisors of Huakang Co., Ltd
Huakang Co., Ltd. Accounting Services Selection and Employment System
No Data